HOME >> BIOLOGY >> NEWS
Bacterial spread all down to chance: Some strains 'just the lucky ones'

Scientists have discovered that factors such as human immunity and drug resistance are less important to the success of bacterial spread than previously thought.

According to research published online this week in Proceedings of the National Academy of Sciences most of the variation in the spread of bacterial pathogens occurs simply by chance.

The team from Imperial College London studied three famously deadly species: Neisseria meningitidis, which causes outbreaks of meningitis; Streptococcus pneumoniae, which kills 1.8 million people around the world every year, and Staphylococcus aureus, which in its drug resistant form is better known as MRSA. They compared the genetic make-up of these bacteria with a computer simulation which allowed them to test various evolutionary scenarios.

They found evidence that bacterial communities mirror the social life of the humans they infect. For example, close family members or friends in the same class at school or nursery are more likely to share an infection due to increased contact. After accounting for these differences in the opportunities for person-to-person spread, the researchers were amazed to find that there was little evidence for differences in the ability of pathogen strains to spread.

Dr Christophe Fraser, from Imperial College London, a Royal Society University Research Fellow and one of the authors, says: "Microbiologists have assumed for some time that some disease strains spread more successfully than others. In fact we found that the variation in the communities we studied could be explained by chance. This was surprising, especially considering all the potential advantages one pathogen can have over another, such as antibiotic resistance and differences in host immunity."

Dr Bill Hanage, from Imperial College London, and also one of the authors, says: "When we look at a sample and see that some strains are much more common than others, it's tempting to think that there
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-20-759-46712
Imperial College London
3-Feb-2005


Page: 1 2

Related biology news :

1. Better together: Bacterial endosymbionts are essential for the reproduction of a fungus
2. Bacterial response to oxidation studied as toxin barometer
3. Bacterial walls come tumbling down
4. Bacterial switch gene regulates how oceans emit sulfur into atmosphere
5. Bacterial protein shows promise in treating intestinal parasites
6. The results are in: Bacterial parasite strives for balance in host infection
7. Bacterial protein mimics host to cripple defenses
8. Say what? Bacterial conversation stoppers
9. Bacterial cooperation as a target for anti-infectious therapy
10. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
11. OHSU study: Bacterial switching mechanism key to survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... 21, 2020 , ... Gateway Genomics , a leading developer of direct-to-consumer ... year’s annual Inc. 5000 list of fastest-growing private companies in the United ... be the 17th fastest-growing private company in the state, and #1 in the Health ...
(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... ... announce an exclusive interview with Nobio CEO Yoram Ashery to discuss ... Nobio is a company that combats bacteria to keep people healthy with their ...
(Date:2/7/2020)... , ... February 07, 2020 , ... ... consulting firm for the natural health product, nutraceutical and dietary supplement industries, announces ... been a leader in regulatory expertise and research pertaining to probiotics. We are ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... 21, 2020 , ... Microbial Discovery Group LLC (MDG) is ... and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners with ... 30 years of sales experience working across multiple different market sectors such as; ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... the vendor qualification process, a critical element of clinical trial set up and ... the vendor qualification process creates delays in initiation in 7% of clinical trials ...
(Date:1/8/2020)... (PRWEB) , ... January 08, 2020 , ... ... metal wire composites that can achieve specific properties for use in harsh environments ... Metal Wire combines up to three metals or alloys to achieve specific ...
(Date:1/7/2020)... ... 07, 2020 , ... Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated ... appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to ... are delighted to welcome Chand and Lee as new directors. They will be of ...
Breaking Biology Technology:
Cached News: